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Using ragweed hay fever as an example of a  type of allergy we record 
serological studies  which  were undertaken  to  explain  the  protection 
resulting from pollen injections.  The results have indicated to us the 
production of an  intfibiting  or immune  type of substance  that  pre- 
vented the  allergen from  reacting with  the  sensitized cell,  and  they 
have  also  demonstrated  the  coexistence of both  sensitizing  and  im- 
mune antibodies in the specifically treated patients. 
The term allergy is used today in a  general sense to designate  a  number of 
specific reactions that have important clinical,  pathological and immunological 
differences. 
It seems possible now to differentiate one group occurring spontaneously in 
man; that is, without artificial  parenteral stimulation, subject to hereditary in- 
fluence and evidenced clinicaUy by an edematous type of reaction that quickly 
follows  contact of the allergen  with the sensitized  cell.  Immunologically this 
group is characterized by skin and mucous membrane sensitization with the sen- 
sitizing antibody demonstrable in the blood serum as well as by the entire absence 
from the blood of precipitins and smooth muscle sensitizing antibody so regularly 
found in artificially induced allergy (anaphylaxis).  A review of the literature on 
these points together with additional studies is contained in an article by Cooke 
and Spain (1).  De Besche (2) has confirmed this work. 
With the discovery of the transferable skin sensitizing antibodies in the serum 
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of allergies of this group, Prausnitz and Kfistner (3) explained, in part at least, 
the mechanism of this type of allergy. 
The pollen sensitization of man (hay fever) is representative of this group.  The 
beneficial  result  of  specific  therapy  in  pollen  allergy has  rested  upon  clinical 
observation.  As a  result of many independent studies for more than 20 years, 
it is now accepted as a fact that such injections afford satisfactory clinical  im- 
munity, but there has not yet been offered any solution of the protective mech- 
anism.  On  account  of  its  frequency,  ragweed  hay  fever  afforded  the  best 
opportunity for such a study. 
EXPERIMENTAL 
On the theory that it might be possible to demonstrate  the existence 
of an immune  substance in the blood of treated hay fever  cases, we 
first proceeded to note the clinical  effects of transfusion, using  treated 
patients as blood donors  for untreated  patients with  the  same sensi- 
tization having active hay. fever, some  with asthma, in the beginning 
of the pollen season. 
In 1931, 1932, 1933 and  1934 twenty cases were transfused and the effects 
carefully  noted.  The  donors  used  had  all  been  actively and  continuously 
treated  for  at  least  a  year, but  in  no  case  had  a  donor  received  a  pollen 
injection within 2  weeks of  the  transfusion.  At  the  time  of  transfusion  all 
donors  were  positive  by intradermal test to ragweed pollen extract and their 
serum  transferred  the  sensitization  to  normal  human  skin.  The  donors 
themselves had  satisfactory clinical  results  through  the  balance of  the pollen 
season. 
The recipients of this theoretically immune blood received no treatment other 
than transfusion and lived their usual lives in the usual pollen atmosphere.  Six- 
teen of the twenty cases had satisfactory results which lasted through the remain- 
ing 4 to 5 weeks of their hay fever season.  96 other patients received repeated 10 
cc. doses of the supposedly immune serum subcutaneously with clinical improve- 
ment in 60 per cent. 
These results, in some cases striking, indicated to us the presence of a 
transferable protecting substance which we then sought to demonstrate 
by serological studies. 
In this work the method of passive transfer was employed, using the skin of 
normal non-allergic people as test subjects to provide test sites made with serum 
of patients sensitive clinicaliy and by test to ragweed pollen.  Bleedings were made 
and serum obtained from the patient group before and after treatment with rag- 
weed extract.  Hereafter in  this  paper the  term test  subject  denotes the  non- R.  A.  COOKE~ J.  H.  BARNARD, S.  HEBALD~ A.  STULL  7~ 
sensitive group whose  skin  was  used  for sites and  tests.  The ante-treatment 
serum is called Serum A, and the post-treatment serum called Serum P.  The 
pollen extracts used  throughout  this work were prepared from ethyl ether ex- 
tracted pollen in alkaline saline fluid and were standardized on the protein nitrogen 
basis  (4)  (100  units ~ 0.001  rag.  protein  nitrogen).  Dilutions  were  made  in 
physiologic salt solution.  As near as we can estimate 60,000 of our units equalled 
100,000  Noon  units  (5)  calculated  on  a  weight  by  volume  basis  as  used 
by Harley (5). 
The synopsis of the histories and essential facts regarding the eight 
cases whose serums in special were studied for this paper is as follows: 
St.  Case 2025.  Male.  Age 40.  Ragweed hay fever with asthma of 12 years 
duration.  Some ragweed injections in 1929.  Intradermal test with ragweed 1,000 
units  marked (4-4-4-4-).  Tests after treatment were approximately the  same. 
Serum A taken Aug. 10,1933.  He was transfused on Aug. 15, 1933, and was one of 
the sixteen cases referred to with satisfactory results in 1933.  Treated at weekly 
intervals with giant ragweed from Oct.  24,  1933, with moderate constitutional 
reactions when dosage exceeded 10,000 units.  Dose reduced to 5,000 units.  The 
last injection was given Oct. 2, 1934.  Serum P taken Oct. 24, 1934, when total 
dosage had been 230,000 units.  90 per cent relief in 1934 (3 days of hay fever). 
Sc.  Case2105.  Male.  Age46.  Ragweed hay fever since1931.  Neverpre- 
viously treated.  Intradermal test with ragweed 1,000 units marked (4- 4- 4- 4-). 
Test after treatment showed very slight  reduction  in activity.  Serum A taken 
Sept. 6, 1933.  Treated at weekly intervals with giant ragweed until 10,000 units 
had been reached, when injections were given every 2 weeks and finally every 
month.  Last five injections 60,000 units each with dosage totalling 585,535 units. 
Last dose given Nov. 17, 1934.  Serum P was taken Jan. 18, 1935.  80 per cent 
relief (7  days hay fever). 
Ce.  Case  2055.  Female.  Age 31.  Ragweed hay fever since  1932.  Never 
previously treated.  Intradermal test with ragweed 1,000 units marked (4- ~  4- 4- ) 
before treatment.  This was reduced during treatment, and was only slight (@) 
to 1,000 units after treatment.  Serum A taken Oct. 20, 1933.  Treated at weekly 
intervals with giant ragweed until 60,000 units was reached.  Last in~ection Aug. 
8,  1934, dosage totalled 301,700 units.  Serum P  taken Sept.  15,  1934.  90 per 
cent relief (3 days hay fever). 
Bu.  Case 2022.  Male.  Age 55.  Ragweed hay fever of 15 years duration. 
Never previously treated.  Intradermal test  with  ragweed marked  (-{--}-4-4-) 
to 1,000 units before treatment  and  approximately the  same  after  treatment. 
Serum A taken Nov. 5, 1933.  Treatment started at weekly intervals with giant 
ragweed until 60,000 units was reached on Sept. 7,  1934.  Total dosage 430,480 
units.  Serum P taken Oct. 1, 1934.  Had no hay fever in 1934. 
Kr.  Case 2042.  Male.  Age 10.  First definite hay fever in 1933 was untreated. 
Intradermal test before treatment on Nov. 10, 1933, marked (4-4-~ 4-) to 1,000 736  ~UNITY  AND  SENSITIZATION IN  ALLERGY 
units and the same after treatment.  Serum A taken Nov. 13,  1933.  Treated 
with low ragweed at weekly intervals until receiving 10,000 units in June, 1934. 
Treatment interrupted until September, 1934, when dosage was reduced to 5,000 
units.  Last dose Sept.  25,  1934, 5,000  units,  totalling 93,190  units.  Serum P 
taken Nov. 2, 1934.  70 per cent relief (9 days of hay fever). 
B1.  Case 2076.  Male.  Age  11.  Ragweed  hay  fever  since  1932.  Never 
previously treated.  Intradermal test marked (4-++-~-) to 1,000 units ragweed 
before treatment.  Tests  after  treatment  showed  slight  reduction  of  activity. 
Serum A  taken  Sept.  6,  1933.  Treated with low ragweed at weekly intervals 
until  21,000 units  was reached and a  constitutional  reaction resulted.  Dosage 
was reduced,  last injection  Oct.  15,  1934, 5,000  units,  totalling  192,280 units. 
Serum P taken Nov. 7, 1934.  70 per cent relief (9 days of hay fever). 
Sp.  Case 2054.  Male.  Age 47.  Ragweed  hay  fever  since  1932.  Never 
previously treated.  Transfused with satisfactory results on Sept. 7, 1933.  Intra- 
dermal reaction  marked  (4-4-4-+)  to  1,000 units  ragweed before treatment. 
Reactions after treatment were a  trifle less in activity.  Serum A  taken Sept. 
19,  1933.  Treated at weekly intervals from October, 1933, with giant ragweed 
up to  10,000 units when the interval was increased to 2 weeks and dosage in- 
creased to  60,000 units.  Total units  473,650.  Last injection  Sept.  21,  1934. 
Serum P taken Oct. 5, 1934.  70 per cent relief (9 days hay fever). 
Bo.  Case 2045.  Female.  Age 38.  Ragweed hay fever since 1931.  Never 
previously  treated.  Intradermal  reactions  marked  (-F++-t-)  to  100  units 
ragweed.  After treatment skin reactions reduced to moderate (+ +) to 100 units. 
Serum A taken Aug. 30,  1933.  Transfused on Aug.  31 with excellent  results in 
1933.  Treatment started Oct.  20,  1933, with giant  ragweed until  60,000  unit 
dose was given.  Kept at that level for four doses until  Sept. 10, 1934, the date 
of last injection.  Dosage totalled 519,240 units.  Serum P taken Sept. 20, 1934. 
85 per cent relief in 1934 ($ days of hay fever). 
Precipitin tests were done on both Serum A and Serum P  of all these cases 
except Kr. and Bo.  The antigens used were giant and low ragweed extracts and 
their pure proteins.  There was no precipitation. 
Our  observations  consisted  of  a  comparison  of  the  Serum  A  and 
Serum P  of each of these eight cases with reference to: 
1.  The relative amounts of skin sensitizing antibody in the Serums 
A  and  P  to  determine  its  increase,  decrease  or  disappearance  under 
treatment. 
2.  The reactions of test subjects' skin both to injections of serum- 
allergen mixtures at the time the transfer sites were made and to the 
subsequent tests of these sites. 
The normal skin test subjects vary somewhat both as to their acceptance of 
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the same test subject at the same time.  Extracts of pollen deteriorate.  We have 
found this to be definite and demonstrable in extracts 2  months old but not at 
1 month.  The extracts used in this work were made fresh every month.  The 
serums must be kept sterile.  The question arose early as to the possible loss of 
skin sensitizing capacity of aging serum.  Levine and Coca (6) have stated there 
was no apparent loss in 3 months' time.  Our tests indicated none in I  year when 
serum was kept sterile at  8°C.  The non-specific reaction produced by heterol- 
ogous  serums  when  injected intradermally for skin sites has introduced some 
dii~culty.  Chant and Gay (7) studied this point and stated that such reactions 
started at once, reached a maximum in 15 minutes and began to fade in less than 
30 minutes.  Our observations were in entire accord.  These "irritative" reactions 
will be discussed later under serum-allergen mixture tests as they have been a cause 
of erroneous interpretation by previous observers. 
1.  Titration of the Relative  Amounts of Skin Sensitizing Antibody  in 
Serums before and after Treatment 
Influenced by observations in experimental anaphylaxis the effects 
of pollen therapy are generally ascribed to desensitization.  In the 
type of allergy represented by hay fever cellular antibody may be 
tested for through the skin by prick, scratch or intradermal method. 
Using the intradermal method, Cooke (8), Levine and Coca (9) and 
others have recorded no material objective change in the test in the 
majority of cases treated to a successful clinical result.  Markin (10), 
Brown (11) and Harley (12) on the contrary have reported abolition 
of skin reaction after treatment using the scratch or prick method. 
These discrepancies may be due to  the difference of technique and 
may be explainable, but if one claims cellular desensitization it should 
be only after use of the more delicate test, the intradermal, and not the 
less delicate, the scratch or prick. 
In the summaries of the eight cases here presented, no significant 
differences could be noted in the intradermal reactions before and after 
treatment with the exception of Ce., No. 2055, where it was definitely 
reduced but not abolished.  Cellular desensitization was not demon- 
strable in these long and excessively treated cases using the intradermal 
test. 
The amount of skin sensitizing antibody in the serum has been deter- 
mined by injecting increasing dilutions of sensitive serum into normal 
skin  (passive  transfer)  and  testing  these  sites  24-48  hours  later. 
Levine and Coca (6) found no decrease of serum antibody in the serum TABLE  I 
Titration  of the Amount  of Skin  Sensitizing  Antibody in Serums  before and after 
Treatment 
Serum 
dilutions* 
1-10 
1-25 
1-50 
1-100 
1-200 
1-300 
1--400 
1-500 
1-700 
Bu. serumt 
(Test subject D.L.) 
__  Serum A  Serum P 
t  ++ 
++  ++  +++ 
+  0 
4-  0 
4-  0 
alP 
q- 
q- 
(Test  subject  M.G.) 
SerumA  SerumP 
++  + 
+  4. 
4.  0 
KF. serum  t 
(Test  subject  H.R.)  . (Test  subject  F.S.) 
Serum____~A 
+++++++ 
+++ 
+++ 
++ 
+ 
S  erg__~P  Serum__.___~A Serum P 
++  I++++ 
++  I+++ 
+  +++ 
+  ++ 
+ 
++++ 
++++ 
+++ 
+++ 
++ 
+ 
Bo. serumt 
Serum 
dilutions*  (Test subject E.S.) 
1-10 
1-25 
1-50  +  ++ 
1-100  -4-  + 
1-200  0  4-4- 
1-300 
1-400 
1-500 
St. serumt  Ce. serumf 
II (T0st W,  tl (T0 u N, 
Serum A  Serum P  Serum A  SeJum__.__~P 
+:  +++  +++  ++ 
+++  I +++  ++ 
+++1+++  o  °  '  o 
+  + 
4.  + 
Sc. serumt 
(Test subject O.C.) 
Serum A  Serum____.~P 
++_~  ++ 
++ 
+ 
+ 
Sp. serumt  B1. serumt 
Serum 
dilutions*  (Test  subject  G.W.)  (Test  subject  C.T.)  (Test  subject  C.T.)  (Test subject  H.R.) 
Serum P 
1-10 
1-25 
1-50 
1-100 
1-200 
1-300 
1-400 
1-500 
Serum A I  Serum P 
I 
+  I+++ 
±  I +++ 
o  +++ 
o  +++ 
Serum A  SerumP 
I++++  F++-~ 
4-  ' F++-~ 
0  +++ 
0  ++ 
0  + 
0  4-4- 
Serum A 
++++ 
+ 
-4- 
0 
0 
o 
Serum P 
+++-~ 
+++ 
++ 
+ 
0 
0 
Serum.____~A __ 
-4- 
0 
0 
0 
+++ 
+++ 
++ 
++ 
+ 
+  =  degree of skin reaction. 
.4-  -- doubtful skin reaction. 
0  =  negative skin reaction. 
A  =  serum taken before treatment with ragweed extract. 
P  =  serum taken after treatment with ragweed extract. 
* 1/10 cc. of these serum dilutions in physiologic saline was placed in each site. 
t The serum dilution sites were tested with 1/40 cc. of low ragweed 100 units 
per cc. 48 hours after they were made. 
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of treated patients.  In some cases it was materially increased.  Gay 
and Chant's (13) findings were in accord.  Harley (12) using the same 
technique stated,  "In  one  case  the  serum  reagin  disappeared  com- 
pletely, in the others they were markedly reduced."  Markin's  (10) 
reports agree. 
This titration of skin sensitizing capacity of serums is of importance 
in the interpretation of the results of the mixture experiments later 
described.  One  can reasonably assume that  a  serum with a greater 
concentration of antibody would transfer its sensitiveness in a higher 
dilution than a  serum in which the antibody was less abundant.  If 
this is so it is also indicated that a serum containing a greater amount 
of  antibody  would  require  a  greater  amount  of  allergen  to  effect 
desensitization.  This is confirmed by our studies, not given here in 
detail, which have shown us that ante-treatment serums that did not 
transfer beyond a 1-10 dilution were neutralized by an equal amount of 
pollen extract containing about 50 units per cc., whereas a serum that 
transferred in a  1-1,000 dilution required an equal amount of extract 
containing nearly six times as many units, hence this dilution method 
is a  relatively accurate means of determining the amount of the skin 
sensitizing antibody. 
In the serums of our eight cases shown in Table I the comparison of 
Serum A  with Serum P  showed equality of sensitizing antibody for 
Kr.,  St., Sc. and Ce.  The Serum P  antibody was slightly decreased 
for Bu., slightly increased for Bo. and B1. and decidedly increased for 
Sp.  As shown in the case histories all these patients received about as 
much  treatment  as  Harley's  cases.  Our  findings support  those  of 
Levine and Coca (6) and Gay and Chant (13) and disagree with those 
of Markin (10) and of Harley (12). 
Serum desensitization was not obtained by us and post-treatment 
serum in all cases was demonstrably an actively sensitizing serum as 
shown by passive transfer  tests, therefore as normally circulating in 
the patient's  body it must keep the tissues sensitive.  That  this is 
true was shown by the direct positive intradermal test on these patients 
after complete treatment.  The only interpretation that can be placed 
on these findings is that  there is no evidence of protection through 
desensitization, cellular or  humoral, nor yet  any  evidence  that  the 
clinical  immunity from specific injections might be  afforded  by  an 
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2.  The Reactions  of Serum-Allergen Mixtures in  Non-Sensitive  Test 
Subjects 
Injections of serum-allergen mixtures into normal skin have been 
recorded, but  no  account seemingly has  been taken  as  to  whether 
the serums in these mixtures were obtained before or after treatment. 
There are no observations in the literature in which a study has been 
made of the comparative behavior of mixtures of allergen with Serum A 
and with Serum P  such as we now record.  Coca and  Grove  (14), 
Levine and Coca (6, 15), Clarke and Gallagher (16), Baldwin (17) and 
others have reported no reactions at the time the sites were made. 
Gay and Chant (13) first reported the finding of positive specific reac- 
tions.  They have been supported by Foran  and Lichtenstein  (18) 
and Harley  (5),  and by our own findings previously  (19)  and now 
recorded.  These contradictory reports may be due to the failure to 
discriminate between serum taken before and that taken during or 
after treatment, or they may be explained by the fact already men- 
tioned that injection of heterologous serum into normal skin produced 
an irritative  non-specific  reaction with wheal and erythema readily 
confused with the specific reaction. 
The non-specific reaction begins at once, reaches its maximum in 15 
minutes,  and  with  most  serums the erythema begins  to  disappear 
before 30 minutes and is practically gone in 1 hour, leaving a  pale 
round  elevated papule.  The  specific reaction begins  more  slowly, 
and  erythema and  wheal  are  still  active  at the end of an hour at 
which time these tests should be read. 
In making allergen-serum mixtures precautions  for  sterility  were 
used.  A definite amount of a serum was mixed with an equal amount 
of the allergen in  varying strengths,  in  these cases ragweed  pollen 
extract.  The mixtures were allowed to stand about 15 hours.  Harley 
(5) contends that there is a binding of allergen to antibody because of 
the negative skin reaction in sensitive patients tested with incubated 
serum-allergen mixtures.  Our previous experiments which we shall 
not give here in detail were carried out in duplicate, one set at 8°C. 
and the other at 37°C.  Care was taken to assure an excess of antibody 
over allergen.  Intradermal tests on ragweed sensitive patients were 
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controlled  by  the  usual  saline  extracts  of  the  same  strength.  No 
differences could be observed, hence Harley's assumption of inactiva- 
tion through binding of antigen by antibody could not be confirmed. 
The serum mixtures used in this study were kept at 8°C.  In order to 
make  this  presentation  clear  the  complete  protocol  of  the  typical 
Experiment 26 will be given. 
Experiment 26.--Bu.'s Serum A and Serum P  were each mixed in test tubes 
with an equal volume of a low ragweed extract (LR34E) of a certain unit strength 
as indicated in Table II.  Also dilutions with physiological saline were made of 
both Serums A and P.  These preparations made Apr. 11,  1935, were allowed to 
stand at 8°C.  overnight and  1/10 cc. of each mixture or dilution was injected 
intradermally on Apr.  12 into each site in the skin of the back of normal test 
subject  (D.  L.).  Twenty-two separate sites were  made  and  marked with  an 
indelible pencil.  The 1 hour reactions of the ten mixtures were recorded.  There 
was of course no  1 hour reaction with  the serum dilutions.  The test subject 
returned on the 14th of April for the tests of the sites.  At this time there was 
injected into each site 1/40 cc. of a ragweed extract (LR34E).  We had chosen 
quite arbitrarily a reasonably strong extract containing 1,000 units per cc. to test 
mixture sites, and a weaker extract, 100 units per cc.,  for testing dilution sites. 
The details of the mixtures and the results are recorded in Table II, and illustrated 
in Figs. 1 and 2. 
These results showed that at the time the sites were made on Apr. 12 the mix- 
tures of ragweed and Serum A gave positive 1 hour reactions but the saline control 
was negative.  (Fig. 1, Column 2.)  On the contrary the Serum P ragweed mixtures 
gave no 1 hour reaction except for a suggestive or doubtful reaction with the 1,000 
unit extract.  This is significant  as it seems to indicate that excess of allergen may 
jump the immune barrier, so to speak, and this suggests the possibility of measuring 
the amount of protective substance (Fig. 1, Column 3). 
When these ten mixture sites were tested on Apr. 14 the Serum A mixtures that 
had previously reacted were now negative, whereas the Serum P  mixtures pre- 
viously negative or doubtful were now positive. 
The comparison of the saline dilutions of Serum A and Serum P  showed a 
slight but definitely greater amount of sensitizing  antibody in Serum A.  Con- 
sidering the extent of treatment recorded in  the synopsis of the Bu.  case this 
cannot be interpreted as desensitization sufficient  to explain  the almost perfect 
clinical result recorded for that season. 
Similar experiments with the serums of the eight cases studied have 
been grouped and the results recorded in Table III.  They are quite 
strikingly  uniform  throughout.  It  is  interesting  to  note  that  all 
Serums A  (except B1.)  had  been  neutralized  by an equal  amount of 742  IMMUNITY  AND  SENSITIZATION  IN  ALLERGY 
TABLE  II 
Experiment  26, Test Subject D.L. 
I  Apr.  11  I  Apr. 12  Apr. 14 
Serum-ragweed mixtures 
Sites  Equal  amounts 
5 
6 
7 
8 
9 
10 
Bu. serum 
A 
A 
A 
A 
P 
P 
P 
P 
P 
P 
Ragweed extract 
units per cc. 
50 
100 
150 
Saline (control) 
150 
300 
500 
700 
1,000 
Saline (control) 
1 hr. reactions when 
sites were made, Fig. 1 
(Column 2) 
+++ 
+++ 
+++ 
0 
(Column 3) 
0 
0 
0 
0 
± 
0 
Reaction to test with 
ragweed 1,000 units 
per cc., Fig. 2 
(Column 2) 
0 
0 
0 
++++ 
(Column 3) 
++ 
++ 
++ 
++ 
+ 
+++ 
Serum dilutions 
Sites  1 hr. reactions when  Reaction to test with 
Bu. serum  SaLine dilution  sites  were made, Fig. I  ragweed i00 units per 
cc.,  Fig. 2 
(Column 1)  (Column 1) 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
A 
A 
A 
A 
A 
A 
1-10 
1-100 
1-200 
1-300 
1-400 
1-500 
1-10 
1-100 
1-200 
1-300 
1-400 
1-500 
(Column 4) 
0 
0 
0 
0 
0 
0 
+++ 
++ 
++ 
+ 
4- 
± 
(Column 
++ 
++ 
+ 
0 
0 
0 
4) 
ragweed 150 units per cc. or less on at least one of two test subjects. 
This means that the sensitizing antibody had been  used up  in the 
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TABLE  III 
Reactions at the Time the Mixture Sites  Were Tested with Ragweed 48 Hours after 
They Were Made 
Mixture for sites*  Reaction of sites when 
WitI~LR  tested48 hrs. later with 
Serum  units per  ragweedt 
cc. 
Mixture for sites* 
With LR 
Serum  units per 
cc. 
(Test sub- i  (Test sub- 
ject M.R.) I ject D. L.) 
A  ~  50  +  0  A  50 
A  '  100  =i=  0  A  i00 
A  !  150  4-  0  A  150 
A  Saline  ++++  ++++  A  Saline 
Bu.  Sc. 
P  150  +++  ++  P  50 
P  300  +  ++  P  100 
P  I  500  +  ++  P  150 
P  I  700  +  ++  P  300 
P  I  1,000  4-  +  P  700 
p  I  Saline  ++++  +++  P  1,000 
P  Saline 
"  (Test sub- i  (Test sub-  "" 
ject M.G.) j  ject T.Y.) 
A]  50  +  A  SO 
A  100  +  A  100 
A  150  0  ++  A  150 
A  Saline  +++  ++++  A  300 
St. 
P  i  50  ++++  BI. 
P  100  ++++  P  50 
P  l  lso  +++  +++  P  loo 
P  F  300  +++ 
P!  500  +++ 
P  ~  700 
P  1,000  +  +  P  700 
P  Saline  ++++  ++++ 
A  Saline 
P  150 
P  300 
P  500 
P  1,000 
P  Saline 
Reaction of sites when 
tested 48 hrs. later with 
ragweedt 
(Test sub-  Test  sub. 
ject M.L.)  iect O.C.) 
~:  + 
0  + 
0 
++++  ++++ 
++++ 
+++  +++ 
+++  +++ 
+++ 
++ 
4-  ++ 
++++  ++++ 
~  Test sub-  (Test  sub. 
ect D.S.)  ject L.L.) 
++ 
+ 
+ 
-4- 
++++  +++ 
++++  +++ 
++++ 
++++ 
++++ 
++++ 
+++ 
+ 
++++  ++++ 
+  -- degree of skin reaction. 
:t:  -- doubtful skin reaction. 
0  -- negative skin reaction. 
* 1/10  of these mixtures of equal volumes of serum and  ragweed extract  or 
serum and saline was placed in each site. 
'f Tested with 1/40 cc. low ragweed 1,000 units per cc. 744  IMMUNITY  AND  SENSITIZATION  IN  ALLERGY 
TABLE III--Conctuded 
Mixture  for sites* 
Serum 
Reaction of sites when 
With LR  ] tested 48 hrs. later with 
units per  ragweedt 
ec. 
(Test sub-  (Test sub- 
A  50 
A  100 
A  150 
A  Saline 
Kr. 
P  5O 
P  100 
P  150 
P  3O0 
P  500 
P  70O 
P  1,000 
P  Saline 
A  50 
A  100 
A  150 
A  Saline 
Ce. 
P  50 
P  100 
P  150 
P  300 
P  5OO 
P  7OO 
P  1,000 
P  Saline 
ieet N.P.)  iect T.Y.) 
+++ 
0  0 
++++  ++++ 
++++ 
++++ 
++++  ++++ 
++++ 
++ 
++ 
0 
++++  ++++ 
i 
(Test sub-  {Test  sub- 
'ject  D.H.)  ject J.N,) 
0  0 
0  0 
0 
++++  ++++ 
+++ 
+++  +++ 
+  ++ 
++  ¢ 
I  ++ 
++ 
0  ++ 
++++  ++++ 
Mixture for sites* 
With Lt 
Serum  units pe 
¢c. 
A  5O 
A  loo 
A  150 
A  Saline 
Sp. 
P  50 
P  100 
P  150 
P  300 
P  500 
P  700 
P  i,OO0 
P  Saline 
A  5O 
A  100 
A  150 
A  Saline 
Bo.~ 
P  50 
P  100 
P  150 
P  1,000 
P  Saline 
Reaction of sites when 
tested 48 hrs. later witt 
ragweed? 
(Test  sub-  (Test  sub 
ject R.H.)  ject L.L.) 
+ 
0  0 
0 
+++  +++ 
++++ 
++++ 
++++  ++++ 
++++ 
++++ 
++++ 
+++ 
--+++  ++++ 
I ~  Test sub-  Test  sub- 
i 
,ect R.B.)  ject E.S.)  +  o 
0 
0  0 
++++  ++++ 
++++  ++++ 
++++  ++++ 
I++++  ++++ 
f++++  ++++ 
r 
i 
] 
To the poorly transferring  Bo. serum treated and untreated a small amount 
of Fe.'s untreated serum was added to increase its skin sensitizing capacity. 
fact  that  the  48  hour  tests  of the  sites  were  negative.  In striking 
contrast is the fact that when Serum P  (except Kr.)  was used in the 
mixtures, every site was still giving positive reaction when tested 48 
hours later, although a  much greater amount of ragweed (1,000 units 
per  cc.)  had  been  used  in  the  mixtures.  In other  words,  Serum  P 
had not been neutralized by a reaction when sites were made even with R. A. COOKE, J. H. BARNARD,  S. HEBALD, A. STULL  745 
this strong extract.  Since we have already shown that there was no 
greater  amount  of sensitizing  antibody  (except  Sp.)  to  require  this 
additional  antigen,  we feel justified in  assuming  the presence of an 
inhibiting agent in the serum of patients after they had been specifi- 
cally treated. 
Before proceeding to our interpretation  of these findings we shall 
record a few supplementary experiments that aid in the solution. 
It was necessary to know that an inhibiting  Serum P  would exert 
the  effect on  the  actively  sensitizing  Serum  A  of  another  patient. 
This was done by combining Bo. Serum P with Fe. Serum A controlled 
by Bo. Serum A and Fe. Serum A.  The inhibiting effect was demon- 
strable (see Table III). 
It was then  shown that  normal  non-sensitive human  serum  com- 
bined with Fe. Serum A did not have an inhibiting effect. 
The next point was to discover whether Serum P  had any binding, 
inactivating or lytic effect on the allergen.  It has already been noted 
that there was no discoverable precipitin in the six serums studied for 
precipitins.  If  Serum  P-ragweed  mixtures  would  give  reactions 
equal to  Serum A-ragweed mixtures when tested on sensitive cases, 
then binding or destruction of allergen could not be maintained.  The 
following experiment was done. 
To Bu. Serum A was added an equal volume of ragweed extract  700 units per 
cc.  A similar mixture was made with Bu. Serum P, and Bu. Serum P with saline 
was used as control.  These three mixtures were incubated at 37°C. for 12 hours 
and then were diluted with saline so that there were, of each mixture, three dilu- 
tions containing  1, 5 and  10 units of ragweed per cc. respectively.  These nine 
dilutions  were then  tested on  ragweed sensitive cases.  The  results  shown in 
Table IV indicated no lessening in the activity of the allergen in the Serum P 
mixture, hence no allergen destruction. 
Another  question  of importance  concerned  the  specificity of  the 
inhibiting  substance.  The  experiments  already  recorded,  as  for 
example the  Serum P  of Bu. who was  treated  with  giant  ragweed, 
and Serum P of B1. who was treated with low ragweed, had both shown 
the  inhibiting  effect  against  the  low  ragweed  extract  (Table  III). 
Experiments which we will not give in detail have further shown that 
Serum P from these two cases also showed an inhibition of the reaction 
against giant ragweed.  Other cases treated with low ragweed extract 746  IMMUNITY  AND  SENSITIZATION  IN  ALLERGY 
showed the inhibition of reaction by Serum P  against giant as well as 
low ragweed  extract,  and  serum of  cases treated  with  giant  extract 
inhibited both giant and low ragweed extract.  Thus both species of 
ragweed produced  a  common inhibiting substance,  and this supports 
TABLE  IV 
Immediate Skin Reactions on Ragweed  Sensitive Cases 
Mixture 1 *  Mixture 2t 
[ Bu. Serum A and low ragweed  Bu. Serum P and low ragweed 
Ragweed I 
sensitive  Units per ee.  Units per ce. 
eases 
1  5 
1  +++  ++++ 
2  +  ++ 
3  ++  +++ 
4  0  0 
5  +  ++ 
6  +  + 
7  ++  +++ 
8  ++  +++ 
9  ++  +++ 
10 
11 
12 
lO 
++++ 
++ 
++++ 
+ 
++ 
+++ 
+++ 
+++ 
+++ 
+  ++++  ++++ 
++  +++  +++ 
++  +++  ++++ 
+++ 
+ 
++ 
0 
+ 
+ 
++ 
++ 
++ 
+ 
++ 
++ 
++++ 
÷ 
+++ 
0 
+ 
++ 
+++ 
+++ 
+++ 
++++ 
++ 
+++ 
10 
++++ 
+ 
+++ 
+ 
+ 
+++ 
+++ 
+++ 
+++ 
++++ 
+++ 
+++ 
Mixture  35 
Bu. Serum P and saline (con- 
trol) in similar dilutions to 
preceding mixturea 
+  +  + 
o  o  0 
+  +  + 
+  +  4- 
o  o  o 
o  o  o 
o  o  o 
o  o  o 
-4-  4-4-  4- 
o  o  o 
o  o  o 
4-  4-  4- 
+  =  extent of skin reaction. 
~-  =  doubtful skin reaction. 
0  =  negative skin reaction. 
* Mixture  1.--Bu.  Serum A  (taken before ragweed treatment)  and low rag- 
weed 700 units in equal parts incubated at 37°C. for 12 hours, then diluted with 
buffered saline to 1, 5, 10 units of ragweed per cc. 
t  Mixture 2.--Bu. Serum P  (taken after ragweed treatment) and low ragweed 
700 units in equal parts incubated at 37°C. for 12 hours, then diluted with buffered 
saline to 1, 5, 10 units of ragweed per cc. 
Mixture 3  (Control).--Bu.  Serum P  and saline  in equal parts incubated at 
37°C.  for 12  hours,  then diluted  comparable to  1,  5 and 10 units of Mixtures 
1 and 2. 
our  clinical  experience  and  our  previous  conclusion  (19)  that  as 
allergens they are qualitatively Mike. 
More important still is the question of whether the inhibiting  sub- 
stance  created  by  the  injection  of  ragweed  pollen  extract  in  the R.  A.  COOKE, J.  H.  BARNARD, S.  HEBALD,  A.  STULL  747 
specifically  sensitive  subject  inhibited  the  skin  reaction  of  timothy 
pollen mixed with its specific serum. 
The following experiment was done. 
Serums from cases of timothy hay fever sensitive only to timothy pollen, taken 
before any treatment with timothy extract, were mixed with ragweed sensitive 
Serum A and ragweed sensitive Serum P.  Equal volumes of the senma combina- 
tions  with  timothy extract  or  serum combinations with  saline  (control)  were 
mixed and placed at 8  ° C. for 18 hours.  Sites were made with 1/10 cc. of  these 
TABLE V 
Spec~city ~ tke Ragweed Inhi~ting Substance 
Mixture for sites* 
Test  Timothy 
subject  Serum combination in equal amounts  units per 
ec. 
R.S.  Timothy Serum A and ragweed Serum A (Sc.) 
Timothy Serum A and ragweed Serum P  (Sc.) 
cc  ~c  cc  cc  g~  c~  ~  ~c 
25 
50 
100 
150 
Saline 
25 
50 
100 
150 
300 
500 
Saline 
Reaction to test 
with 1/40 cc. 
timothy 1,000 
units per cc. 
+ 
o 
o 
o 
+++ 
+ 
0 
0 
0 
0 
0 
+++ 
-k  =  extent of skin reaction. 
0  -- negative skin reaction. 
* 1/10 cc. of these mixtures of serum combinations and timothy  extract or 
serum combinations and saline was placed in each site. 
mixtures in the skin of non-sensitive test subjects.  In 48 hours  the  sites  were 
tested with timothy extract.  Table V is a typical example of these experiments. 
This experiment yielded no evidence of any inhibiting effect by the 
ragweed immune substance even against as closely related a  reaction 
as that produced by timothy pollen and its specific serum on normal 
skin  cells.  Such  experiments must  be  widely  extended  with  many 
allergens and their specific serums to establish absolute specificity of 748  IMMUNITY  AND  SENSITIZATION  IN  ALLERGY 
the inhibiting or immune substance.  Our results thus far indicate 
specificity. 
The final point which we have considered in working toward an 
explanation of the primary inhibition of the skin reaction (at the time 
the mixtures are injected) when ragweed was mixed with  Serum  P, 
deals with the question of a possible neutralization of the theoretical 
histamine-like substance.  Two points already brought out indicate 
that this is not the case.  The H-substance of Lewis (20), if responsible 
for these specific reactions, must be produced as a result of the action 
of allergen on the sensitized cell.  There was no specific reaction when 
the mixtures of Serum P  and ragweed were injected into normal skin 
because there was a reaction when the sites were tested after 48 hours. 
If there had been a reaction as with Serum A the sites when tested 48 
hours later would have been negative. 
Again if these specific reactions were due to  H-substance,  and if 
absence of reactions with allergen-Serum P  mixtures were due to an 
antihistamine effect in Serum P, then it should follow that the inhibit- 
ing effect of Serum P would be non-specific; but we have already shown 
that the inhibition is specific for ragweed as against timothy allergen. 
A  direct approach to the solution of this question has been made 
by testing the skin of normal persons  and allergic patients with  a 
solution of histamine in Serum A and in Serum P.  The comparative 
reactions were so similar that there was no evidence of any antihist- 
amine substance in Serum P. 
DISCUSSION 
In an interpretation of the facts brought out by these comparative 
studies of Serums A and Serums P  the crucial point is to explain the 
inhibition of the reaction with the Serum P  mixtures in normal skin 
at the time the sites are made.  The cell is there, the allergen is there, 
and we have proven by titration that practically as much and some- 
times even more of the skin sensitizing antibody is there.  Then why 
no reaction?  We have shown that there is no binding, no inactivation 
or lysis of the allergen.  We have also explained that results cannot be 
interpreted as neutralization of H-like substance.  What is evident is 
that injection of allergen-Serum P  mixtures  into  skin  produces  no 
specific reaction at the time the sites are made, but the skin sensitizing 
antibody is found sensitizing the skin cells at the site when tested 48 R.  A.  COOKE, J.  H.  BARNARD, S.  HEBALD,  A.  STULL  749 
hours later.  It  seems then that  we must assume a  block by some 
sort of specific inhibiting antibody.  The block does not occur between 
the  cell and  the  sensitizing antibody since the cells are later found 
sensitive.  It  must occur  between  the  allergen  and  the  sensitizing 
antibody, but since the test of the site is positive at the end of 2 days 
we must also assume that both inhibiting substance and allergen are 
shortly removed from the site.  Also it is evident that the block is not 
absolute but  may be  overcome by  the  use  of  a  sufficiently  strong 
allergen in the mixture.  In other words, the capacity to inhibit may 
be roughly measured. 
Assuming,  as  we feel we have  shown,  the presence of  a  specific 
substance which blocks the antigen from the sensitized cell, the question 
may properly be raised whether this is the explanation of the clinical 
immunity  afforded  by  specific  treatment  in  this  type  of  allergy. 
While  it may not be the complete answer it satisfies many of the re- 
quirements.  It permits one to understand the existing sensitization, 
shown by positive skin tests, while there is symptomatic freedom and 
it explains the occurrence of general reactions during treatment from 
dosage that will override the block.  A  more  exacting  test  will  be 
the determination that the amount of symptomatic freedom is pro- 
portional to  the  amount of inhibiting substance found.  Studies to 
determine this point are being made. 
SUM'~ARY 
Using ragweed hay fever as the representative of a  certain type of 
allergy we have made studies to determine if possible the mechanism of 
the protection afforded by specific injections thus far established only 
by clinical observation. 
1.  Blood transfusions and serum injections from clinically immune, 
treated patients  stopped the clinical reaction in untreated patients, 
thus indicating a transferable immunity. 
2.  The amount of skin sensitizing antibody in the serum was found 
to be practically unchanged by specific injections. 
3.  Injection of allergen-antibody mixtures into normal skin showed 
an  immediate  (1  hour)  reaction  when  sites were  made if  serum of 
untreated  cases  (Serum A)  was  used but  none or slight reaction  if 
serum of treated cases (Serum P) was used. 
4.  When  sites made with allergen-antibody mixtures were  tested 750  IMMUNITY  AND SENSITIZATION IN  ALLERGY 
after  48  hours,  reactions  were  absentwith Serum  A mixtures  if  enough 
allergen  had beenused, but were positive  with mixtures of Serum P 
even though a much stronger  allergen  was contained in the mixture. 
5. The primary inhibition  of reactions  with mixtures including 
Serum P was not due to antihistamine  effect  nor to binding of skin 
sensitizing  antibody  nor  to  binding  or  lysis  of  allergen. 
6. The inhibiting  antibody  appears to  be specific. 
7. These serological  studies  supported by transfusion  experiments 
have been interpreted  by us as  showing  the development under treat- 
ment  of  a  peculiar  blocking  or  inhibiting  type  of  immune antibody that 
prevented the  action  of  allergen  on the  sensitizing  antibody and  hence 
showed in the type of human allergy under consideration (hay fever) 
the coexistence of sensitization and immunity. 
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EXPLANATION OF PLATE 31 
The figures illustrate Experiment 26 and the results recorded  in Table II. 
FIo. 1.  1 hour reactions when sites made, Apr. 12, 1935. 
FIG. 2.  Reactions when sites tested, Apr. 15, 1935. THE JOURNAl... OF EXPERIMENTAL MEDICINE VOL.  62  PLATE 31 
(Cooke el al.: Immunity and sensitization in allergy) 